Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi Therapeutics has signed an exclusive agreement
30 January 2014
OncoArendi Therapeutics has closed its angel investment round raising
21 January 2014
OncoArendi has signed a contract agreement with the Polish Agency for Enterprise Development
5 November 2013
The Nencki Institute of Experimental Biology has just signed
6 June 2013
A patent application for the OAT-449
9 April 2013
Funding received for the first discovery program
7 September 2012
Events & Presentations
ESMO – 8-12 September 2017 Madrid
1 September 2017
ERS – 9-13 September 2017 Milan
1 September 2017
BIO USA – San Diego 19-22 June 2017
1 June 2017
ATS – Washington 19-24 May 2017
1 May 2017
This site is registered on
wpml.org as a development site.
